Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Record identifier

TN_cdi_proquest_miscellaneous_2594295783

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2594295783

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Full title

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Publisher

United States: Nature Publishing Group

Journal title

Nature medicine, 2021, Vol.27 (11), p.1904-1909

Record Identifier

TN_cdi_proquest_miscellaneous_2594295783

Language

English

Formats

Publication information

Publisher

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_miscellaneous_2594295783

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2594295783

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card